Merck (MRK) Receivables (2009 - 2026)
Merck (MRK) reported Receivables of $12.56 billion for Q2 2026, up 6.1% from $11.85 billion a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Merck posted Receivables of $11.78 billion, up 14.6% from FY2024.
- Receivables has a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- By year, Receivables came in at $10.28 billion in FY2024 (-0.7%), $10.35 billion in FY2023 (+3.9%), $9.96 billion in FY2022 (-2.3%) and $10.19 billion in FY2021 (+49.8%).
- The Q2 2026 figure ranks as the highest quarterly Receivables in data going back to Q2 2009.
- Year over year, Receivables has now increased in each of the last five quarters, with growth averaging 5.7% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q4 2021 (growth of 49.8%); the low point was Q1 2025 (a decline of 5.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $12.21 billion (Q1 2026), $11.78 billion (Q4 2025) and $12.12 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 10.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.56 Bn |
| Mar 31, 2026 | 12.21 Bn |
| Dec 31, 2025 | 11.78 Bn |
| Sep 30, 2025 | 12.12 Bn |
| Jun 30, 2025 | 11.85 Bn |
| Mar 31, 2025 | 10.79 Bn |
| Dec 31, 2024 | 10.28 Bn |
| Sep 30, 2024 | 11.38 Bn |
| Jun 30, 2024 | 11.64 Bn |
| Mar 31, 2024 | 11.37 Bn |
| Dec 31, 2023 | 10.35 Bn |
| Sep 30, 2023 | 10.39 Bn |
| Jun 30, 2023 | 11.03 Bn |
| Mar 31, 2023 | 10.89 Bn |
| Dec 31, 2022 | 9.96 Bn |
| Sep 30, 2022 | 10.05 Bn |
| Jun 30, 2022 | 10.29 Bn |
| Mar 31, 2022 | 10.55 Bn |
| Dec 31, 2021 | 10.19 Bn |
| Sep 30, 2021 | 9.97 Bn |
API Access
Merck Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();